GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Stockholm, May/June 2006

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 214-219

  Helliwell, Philip S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE CLASSIFICATION; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SWEDEN;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; HUMANS; INTERNATIONAL COOPERATION; METHOTREXATE; PRACTICE GUIDELINES; PSORIASIS; QUALITY OF HEALTH CARE; SWEDEN;

EID: 33846221542     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Taylor WJ, Gladman DD, Helliwell PS, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
2. Kavanaugh A, Ritchlin CT, and the GRAPPA Treatment Group. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006;33:1417-21.
3. Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt G. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA 1995;274:570-4.
4. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization. Ann Intern Med 2003;139:493-8.
5. Gladman DD, Mease PJ, Krueger G, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2005;32:2262-9.
6. Gladman DD, Mease P, Healy PJ, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2007; (in press).
7. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005;64 Suppl H:ii3-ii8.
8. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 1998;57:135-40.
9. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med 1993;16:1-7.
10. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998;352:1137-40.
11. Helliwell PS, Porter G. Sensitivity and specificity of plain radiographic features of enthesopathy in psoriatic arthritis. Clin Radiol 2006; (in press).
12. Helliwell PS, Porter G, Taylor WJ. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2006; Jul 13; Epub ahead of print.
13. Jones A, Ledingham J, Regan M, Doherty M. A proposed minimal rheumatological screening history and examination. J Royal Coll Phys Lond 1991;25:111-5.
14. Klein R. The troubled transformation of Britain's National Health Service. New Engl J Med 2006;355:409-15.
15. Weinblatt ME. Methotrexate in rheumatoid arthritis: toxicity issues. Br J Rheumatol 1996;35:403-6.
16. Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 1991;90:711-6.
17. Cassell S, Tutuncu Z, Kremer J, et al. Psoriatic arthritis patients have different rates of adverse events than rheumatoid arthritis patients when treated with tumor necrosis factor inhibitors: Analysis from the CORRONA database [abstract]. Arthritis Rheum 2005;52 Suppl:S211.